Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Aug 21, 2024 3:12pm
50 Views
Post# 36190492

RE:All Aboard..

RE:All Aboard..Now that V4.0 is ok for Canada, exciting time .Solutions to cardiac clinicians worldwide.
Ventripoint Diagnostics Ltd. has received a medical device license from Health Canada for its latest product offering, VMS+4.0. This is a major milestone for Ventripoint as it continues to innovate and provide cutting-edge solutions to cardiac clinicians worldwide.
Good volume  

V:VPT - VentriPoint Diagnostics Ltd. - https://www.ventripoint.com
Sym-X Offre - Demande Dernier Chg %Ch Vol $Vol #Tr Ouvert-Hi-Lo Anne Hi-Lo Dernier Tr Nouvelles Retard
VPT -V   1,5 0,195 · 0,20 56,0 0,20 +0,015 8.1 290,5 57 159 0,20   0,21   0,19 0,36 0,135 14:42:31 13:01 15 minutes aller-retour 2¢
Bourse de croissance TSX-V-V 1,5 0,195 · 0,20 56,0 0,20 +0,015 8.1 93,6 19 49 0,20   0,2075   0,20 0,36 0,135 12:00:43   15 minutes
NEO ATS-U   0,20 +0,015 8.1 36.0 7 6 0,205   0,205   0,195   12:00:43   15 minutes
Alpha-A   0,20 +0,015 8.1 54.0 11 16 0,205   0,21   0,195   14:42:31   15 minutes
Omga-O   0,20 +0,015 8.1 72.0 14 46 0,20   0,205   0,195   14:42:31   15 minutes
Pur - P   0,185     0,6   2        13 aot   15 minutes
Chi-X-X   0,20 +0,015 8.1 2.0 0 2 0,20   0,20   0,20   09:46:52   15 minutes
CX2-H   0,20 +0,015 8.1 28,5 5 20 0,20   0,205   0,19   13:55:01   15 minutes
CXD-D   0,185     0,4   4        13 aot   15 minutes
TriAct-M   0,185     3.3 1 14        05-19 dc.   15 minutes

<< Previous
Bullboard Posts
Next >>